Tag:
Phase Forward
Latest Headlines
Latest Headlines
Medidata faces market hurdles, Goldman says
Competition is mounting in the clinical trials software game, and drug developers are expected to temper their R&D spending in the coming years. These are two challenges that face major
Medidata Solutions' revenue up, CEO notes rival's integration issues
Medidata ( $MDSO ) is gaining steam in the market for clinical trials software, even though its first-quarter revenue came in just short of some analysts' expectations. It's been interesting to watch
PRODUCT UPDATE: Oracle Clinical Development Center 3.1
Oracle responds to the data-intensive and increasingly networked drug R&D environment in its Health Sciences Clinical Development Center 3.1 . The new version begins as an update to the CDC
Oracle rouses Phase Forward in coding release
In a classic little-pond/big-pond migration story, Oracle has released version 3.0 of its Health Sciences Central Coding, a data coding and dictionary management application. The upgrade enhances
Healthcare reform drives investor to IT opportunities
Venture capital firm SV Life Sciences has positioned itself in the U.S. health IT sector, which it expects to bloom given incentives aimed at helping doctors automate. Its latest fund, the $523
PharmaPros launches e-clinical SaaS offering
Small and mid-size drug developers are the target of eClinical OnDemand, a SaaS offering from trial data workflow solutions provider PharmaPros. The subscription-based service comprises select
Phase Forward brings SaaS affordability to Oracle's clinical lineup
Oracle is preparing to swallow Phase Forward in a deal expected to close mid-year. The enterprise software giant, already well entrenched in clinical circles via the continuing build-out of
Oracle buys Phase Forward for $685M
Oracle announced today that it's purchasing Phase Forward for $17.00 per share in cash, or about $685 million. The deal, which is expected to close in mid-2010, represents a 30 percent premium over
Integrium's enrollment skill drives need for real-time tracking
As reported last week, full-service CRO Integrium, a specialist in running trials for dermatology, cardiovascular and metabolic disease treatments, has signed with Phase Forward for the latter's
Cite competitive plus to justify informatics
Greg Nelson ponders whether clinical informatics provides a competitive advantage for drug developers. The CEO of business intelligence company ThotWave Technologies says the answer is yes, if
